Company intelligence / Profile preview

Supiel

Madrid, Madrid, Spain

Ownership: Private
Development stage: Other

Overview

Supiel is a Spanish biotechnology company dedicated to the development of advanced solutions for skin health, regeneration, and longevity. The company utilizes a proprietary platform focused on bioactive compounds and growth factors to address skin aging and dermatological repair at a cellular level. By leveraging research into the extracellular matrix and cellular signaling, Supiel aims to create high-efficacy treatments that restore skin function and appearance. Their portfolio targets both the aesthetic dermatology market and clinical applications in wound healing and tissue repair.

Therapeutic areas: Dermatology
Modalities: BiologicPeptidesProtein
Industry: Biotech

Beyond the preview

Go deeper on Supiel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Supiel.

Explore the full profile